Initial Experience Following The Bilateral Implantation Of Eyecryl-Sert Advanced Monofocal Intraocular Lens(Iol).

To evaluate the safety, efficacy, functional vision and patient satisfaction with the bilateral implantation of Eyecryl-Sert Advanced monofocal IOL.

Nethradhama Superspeciality Eye Hospital, Bangalore, India.

In this prospective study, patients who met the eligibility criteria and underwent cataract surgery with Eyecryl-Sert Advanced Monofocal IOL ( Biotech Healthcare, Ahmedabad, India) were included. The main visual outcomes were:  spherical equivalent(SE), binocular uncorrected distance visual acuity(UDVA), corrected distance visual acuity(DCVA), uncorrected intermediate visual acuity(UCIVA), distance corrected intermediate visual acuity(DCIVA) at 60 and 80 cm, also uncorrected near visual acuity(UNVA) and corrected near visual acuity (CNVA) at 40 cm. Defocus curve and patient satisfaction were also assessed.

30 eyes of 15 patients were included. At 1 month follow-up, the SE of ±0.5D was achieved in 100% of the eyes implanted with the IOL under study.All the patients attained a binocular CDVA of 20/20 Snellen’s equivalent & UDVA of >20/25.At 60 cm, a satisfactory UCIVA of 20/20 was seen in 13 patients, while 11 patients achieved a UCIVA of 20/25 at 80 cm.The UNVA performance at 40 cm of <0.4 LogMAR units was recorded in all the patients, out of which 2 patients achieved a UNVA of 0.2 LogMAR units.No patient reported of any significant haloes, glare or bothersome dysphotopsia.All patients reported excellent satisfaction with their distance and intermediate vision, while 2 patients achieved complete satisfaction for all distances, including near. 

The new Eyecryl-Sert Advanced Monofocal IOL with wavefront technology and optimized refractive zones appears to provide a continuous vision from distance to intermediate with an acceptable near vision, resulting in good patient satisfaction and minimal photic phenomenon.